Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Prizes
Activities
Press/Media
Student theses
Search by expertise, name or affiliation
Postprandial dysmetabolism and large-vessel disease.
P. Segal
*
*
Corresponding author for this work
Sheba Medical Center at Tel Hashomer
Research output
:
Contribution to journal
›
Review article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Postprandial dysmetabolism and large-vessel disease.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Small Vessel Disease
100%
Postprandial Dysmetabolism
100%
Cardiovascular Risk
50%
Cardiovascular Disease
50%
Cardiovascular Mortality
50%
Fasting Plasma Glucose
33%
Type 2 Diabetic Patients
33%
Blood Glucose
33%
Impaired Glucose Tolerance
33%
Cardiovascular Disease Morbidity
33%
Postchallenge Hyperglycemia
33%
Glycaemia
33%
Hemoglobin A1c (HbA1c)
16%
Epidemiological Study
16%
Strong Predictor
16%
Glycemic Control
16%
Myocardial Infarction
16%
Possible Mechanisms
16%
Glucose Concentration
16%
Japanese Patients
16%
Suboptimal Glycemic Control
16%
Control Results
16%
Pre-diabetes (pre-DM)
16%
Postprandial Glucose
16%
Post-challenge
16%
Intensive Insulin Therapy
16%
Postprandial Hyperglycemia
16%
Postprandial Challenge
16%
Medicine and Dentistry
Cardiovascular Disease
100%
Large Vessel Disease
100%
Maturity Onset Diabetes of the Young
75%
Blood Glucose
37%
Impaired Glucose Tolerance
37%
Hyperglycemia
25%
Patient with Type 2 Diabetes
25%
Glycemic Control
25%
Prevalence
12%
Hemoglobin A1c
12%
Myocardial Infarction
12%
Insulin Treatment
12%
Cardiovascular Disease Risk Factor
12%
Postprandial Hyperglycemia
12%
Nursing and Health Professions
Disease
100%
Cardiovascular Disease
100%
Glucose Blood Level
55%
Non Insulin Dependent Diabetes Mellitus
44%
Hyperglycemia
33%
Impaired Glucose Tolerance
33%
Diabetes Mellitus
22%
Patient with Type 2 Diabetes
22%
Prevalence
11%
Heart Infarction
11%
Hemoglobin A1c
11%
Insulin Treatment
11%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Cardiovascular Disease
100%
Non Insulin Dependent Diabetes Mellitus
66%
Hyperglycemia
33%
Impaired Glucose Tolerance
33%
Prevalence
11%
Heart Infarction
11%
Hemoglobin A1c
11%